Werewolf Therapeutics Inc

Werewolf Therapeutics Insider Dumps 43,000 Shares in Rule‑10b5‑1 Sale, Shifting Confidence and Ownership Dynamics.

Werewolf Therapeutics insider selling surge: EVNIN LUKE’s rule‑10b5‑1 block sale shows strategic liquidity, not a fire‑sale, and may impact shareholder confidence.

Werewolf Therapeutics Inc
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

15/01/2026, 23:38

3 minutes to read

Werewolf Therapeutics Insider Selling Surge: 40,000‑Share Dump Raises Questions About Future Catalyst Plans

Werewolf Therapeutics insider sales spike: 41,000+ shares off‑market, price dips, potential strategic shift—watch upcoming IND‑KINE data for upside.

Werewolf Therapeutics Inc
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

07/01/2026, 23:28

3 minutes to read